A detailed history of American Century Companies Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 1,763,508 shares of GILD stock, worth $159 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,763,508
Previous 2,386,589 26.11%
Holding current value
$159 Million
Previous $164 Million 9.73%
% of portfolio
0.09%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$66.59 - $83.99 $41.5 Million - $52.3 Million
-623,081 Reduced 26.11%
1,763,508 $148 Million
Q2 2024

Aug 07, 2024

SELL
$63.15 - $72.88 $3.83 Million - $4.41 Million
-60,574 Reduced 2.48%
2,386,589 $164 Million
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $7.72 Million - $9.41 Million
-107,805 Reduced 4.22%
2,447,163 $179 Million
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $187 Million - $212 Million
2,554,968 New
2,554,968 $207 Million
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $10.6 Million - $11.6 Million
143,570 Added 6.22%
2,452,616 $184 Million
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $2.89 Million - $3.3 Million
38,029 Added 1.67%
2,309,046 $178 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $85.6 Million - $97.5 Million
1,106,924 Added 95.09%
2,271,017 $188 Million
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $5.99 Million - $8.61 Million
96,194 Added 9.01%
1,164,093 $99.9 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $51.3 Million - $58.6 Million
-860,979 Reduced 44.64%
1,067,899 $65.9 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $75.1 Million - $84.6 Million
1,301,884 Added 207.64%
1,928,878 $119 Million
Q1 2022

May 11, 2022

BUY
$57.92 - $72.58 $388,469 - $486,794
6,707 Added 1.08%
626,994 $37.3 Million
Q4 2021

Feb 07, 2022

BUY
$64.88 - $73.64 $3.13 Million - $3.56 Million
48,295 Added 8.44%
620,287 $45 Million
Q3 2021

Nov 10, 2021

BUY
$67.69 - $73.03 $2.38 Million - $2.57 Million
35,163 Added 6.55%
571,992 $40 Million
Q2 2021

Aug 05, 2021

SELL
$63.47 - $69.35 $19 Million - $20.7 Million
-298,873 Reduced 35.76%
536,829 $37 Million
Q1 2021

May 14, 2021

BUY
$60.0 - $68.46 $5.76 Million - $6.57 Million
95,939 Added 12.97%
835,702 $54 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $11.5 Million - $13.1 Million
-202,897 Reduced 21.52%
739,763 $43.1 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $869,958 - $1.09 Million
-14,009 Reduced 1.46%
942,660 $59.6 Million
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $19.1 Million - $22.1 Million
-263,576 Reduced 21.6%
956,669 $73.6 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $129 Million - $165 Million
-2,052,154 Reduced 62.71%
1,220,245 $91.2 Million
Q4 2019

Feb 12, 2020

SELL
$61.62 - $67.78 $24.2 Million - $26.6 Million
-392,498 Reduced 10.71%
3,272,399 $213 Million
Q3 2019

Nov 13, 2019

SELL
$62.51 - $69.0 $27.7 Million - $30.6 Million
-443,758 Reduced 10.8%
3,664,897 $232 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $198 Million - $222 Million
3,200,233 Added 352.28%
4,108,655 $278 Million
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $7.09 Million - $7.94 Million
113,342 Added 14.26%
908,422 $0
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $40.9 Million - $53.4 Million
675,782 Added 566.47%
795,080 $49.7 Million
Q3 2018

Nov 02, 2018

SELL
$71.28 - $78.92 $205 Million - $227 Million
-2,873,908 Reduced 96.01%
119,298 $9.21 Million
Q2 2018

Aug 08, 2018

SELL
$64.88 - $75.68 $42.4 Million - $49.5 Million
-653,904 Reduced 17.93%
2,993,206 $212 Million
Q1 2018

May 03, 2018

BUY
$72.84 - $88.8 $18.7 Million - $22.7 Million
256,127 Added 7.55%
3,647,110 $275 Million
Q4 2017

Feb 02, 2018

BUY
$71.15 - $83.52 $204,698 - $240,287
2,877 Added 0.08%
3,390,983 $243 Million
Q3 2017

Nov 01, 2017

BUY
$72.11 - $85.47 $244 Million - $290 Million
3,388,106
3,388,106 $275 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.